Steven W. Lefkowitz
At a glance: Steven W. Lefkowitz is Director at CorMedix (CRMD). Their latest SEC Form 4, filed Nov 20, 2026, reported a purchase of $52K. On file: 1 purchase line ($52K) and 1 sale line ($475K).
Disclosed holdings: about $692K of CRMD stock: 137,451 shares reported on their latest Form 4 (filed Nov 20, 2026), valued at the Nov 19, 2026 close of $5.04. This counts only CRMD shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at CorMedix Inc. (CRMD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Steven W. Lefkowitz's InsiderPrint
3 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Mostly buys, trading about once a year, typically $52K a trade; often buys after the stock has fallen 15% or more.
- Bump outward: a purchase (2)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Tonya Williams BradfordDirector · LOB · 99% match
- Jacki Sue KelleyDirector · FRPT · 98% match
- Barclay CorbusCEO, President · CLNE · 98% match
- Carol Anthony DavidsonDirector · FMC · 96% match
- Philip N. GarfinkleDirector · WYY · 94% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2020
From the SEC's insider data sets: each open-market buy by Steven W. Lefkowitz, matched to how the stock did over the next 90 days against the S&P 500.
1 of 1 buy beat the S&P 500 (100%), median +78.3% vs. the index. Small sample: treat with care. All insider buys: 46%.
| Stock | Filed | 90 days vs. S&P 500 |
|---|---|---|
| CRMD | Sep 9, 2020 | +78.3% |
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 20 NewSEC | CRMDCorMedix Inc.First buy in 6 yrs | Buy | 11,500137,451 held (+9%) | $4.53 | $52K | — |
| Dec 10SEC | CRMDCorMedix Inc. | Sell | 40,00080,498 held (−33%) | $11.88 | $475K | -57.6% |
- Buy
Director Steven W Lefkowitz bought $52K of CRMD at $4.53 — first open-market purchase in our records.
- Sell
Director Steven W Lefkowitz sold $475K of CRMD at $11.88 — cuts the stake by 33%.
Follow Steven W. Lefkowitz
Get one email when Steven W. Lefkowitz files a new purchase or sale. Free.
At most one email a day about Steven W. Lefkowitz, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.